 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Recommend company
|
9407 20 Avenue T6N 1E5 Edmonton, Alberta
Canada
|
|
Portrait Quest PharmaTech Inc. is a publicly traded, Alberta-based pharmaceutical company committed to build shareholder value through discovery, development and commercialization of new pharmaceutical products. It is developing a series of products for the treatment of cancer and dermatological conditions based on its unique photodynamic and sonodynamic therapy platform. The Company's lead dermatology product, SL017, is a topical formulation that is currently undergoing a 90 patient clinical trial in Canada for hair removal applications. The Company's lead oncology product, SL052, is scheduled to enter a Phase I clinical trial during the second half of 2008. Quest recently signed an agreement with a multinational technology development company to receive $3,000,000 to develop oncology products based on its SonoLight technology.
Industrial Sectors
Additional information
Quest PharmaTech Inc. Edmonton, Alberta, Canada
News
|
|
|
|
|
|